Latest News - Aldeyra Therapeutics

Wednesday, November 29, 2017 | Clinical Trials, Aldeyra Therapeutics

Aldeyra Therapeutics Presents Noninfectious Anterior Uveitis Phase 2 Clinical Trial Data

Aldeyra Therapeutics presented new statistical analyses of the results of a randomized, multicenter, investigator-masked, comparator-controlled, parallel-group phase 2 clinical trial of topical o…

Read the full story

Wednesday, October 25, 2017 | Clinical Trials, Aldeyra Therapeutics

Aldeyra Therapeutics to Present Efficacy Results of ADX-102 in Noninfectious Anterior Uveitis

Aldeyra Therapeutics announced it will present data from the previously announced phase 2 clinical trial in noninfectious anterior uveitis (NAU) demonstrating statistical noninferiority of ADX-102 to …

Read the full story

Friday, May 13, 2016 | Clinical Trials, Aldeyra Therapeutics

Aldeyra Therapeutics Announces Positive Results From Phase 2 Clinical Trial in Subjects With Noninfectious Anterior Uveitis

Aldeyra Therapeutics reported that a randomized, multicenter, investigator-masked, comparator-controlled, parallel-group phase 2 clinical trial of topical ocular NS2, a first-in-class aldehyde trap, d…

Read the full story

Wednesday, March 02, 2016 | Clinical Trials, Aldeyra Therapeutics

Aldeyra Therapeutics Reports Positive Results From Phase 2a Clinical Trial in Subjects With Allergic Conjunctivitis

Aldeyra Therapeutics reported that the results of a randomized, parallel-group, single-center, double-masked, vehicle-controlled phase 2a clinical trial of topical ocular NS2 in subjects with induced …

Read the full story